These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7066054)

  • 1. Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis.
    Katz EZ; Ehrenfeld M; Levy M; Eliakim M
    Arthritis Rheum; 1982 Feb; 25(2):227-31. PubMed ID: 7066054
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever).
    Bar-Eli M; Ehrenfeld M; Levy M; Gallily R; Eliakim M
    Am J Med Sci; 1981; 281(1):15-8. PubMed ID: 7468635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term colchicine therapy of familial Mediterranean fever.
    Lehman TJ; Peters RS; Hanson V; Schwabe A
    J Pediatr; 1978 Nov; 93(5):876-8. PubMed ID: 712499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine concentration in leukocytes of patients with familial Mediterranean fever.
    Chappey O; Niel E; Dervichian M; Wautier JL; Scherrmann JM; Cattan D
    Br J Clin Pharmacol; 1994 Jul; 38(1):87-9. PubMed ID: 7946943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of long-term colchicine therapy in patients with recurrent polyserositis on the capacity of blood platelets to synthesize thromboxane A2.
    Levy M; Eldor A; Zylber-Katz E; Eliakim M
    Br J Clin Pharmacol; 1983 Aug; 16(2):191-4. PubMed ID: 6615693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Colchicine-aspirin for recurrent polyserositis (familial Mediterranean fever).
    Eliakim M; Light A
    Lancet; 1973 Dec; 2(7841):1333. PubMed ID: 4127683
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis).
    Majeed HA; Carroll JE; Khuffash FA; Hijazi Z
    J Pediatr; 1990 Jun; 116(6):997-9. PubMed ID: 2112191
    [No Abstract]   [Full Text] [Related]  

  • 8. Colchicine treatment in familial Mediterranean fever: an indirect effect on in vitro serum amyloid A secretion via leukocyte derived factors.
    Barash J; Pirogovski A; Livneh A; Brezniak N; Dror Y; Hahn T
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S76. PubMed ID: 11760407
    [No Abstract]   [Full Text] [Related]  

  • 9. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.
    Kallinich T; Haffner D; Niehues T; Huss K; Lainka E; Neudorf U; Schaefer C; Stojanov S; Timmann C; Keitzer R; Ozdogan H; Ozen S
    Pediatrics; 2007 Feb; 119(2):e474-83. PubMed ID: 17242135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colchicine (problems of its pharmacokinetics, mechanism of action and use in therapeutic practice)].
    Kochubeĭ LN; Tatevosian KG
    Revmatologiia (Mosk); 1985; (2):61-4. PubMed ID: 3901198
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma dopamine beta-hydroxylase activity in familial Mediterranean fever.
    Courillon-Mallet A; Cauet N; Dervichian M; Launay JM; Cattan D
    Isr J Med Sci; 1992 Jul; 28(7):427-9. PubMed ID: 1506166
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term colchicine prophylaxis in familial Mediterranean fever.
    Levy M; Eliakim M
    Br Med J; 1977 Sep; 2(6090):808. PubMed ID: 912334
    [No Abstract]   [Full Text] [Related]  

  • 13. Colchicine in breast milk of patients with familial Mediterranean fever.
    Ben-Chetrit E; Scherrmann JM; Levy M
    Arthritis Rheum; 1996 Jul; 39(7):1213-7. PubMed ID: 8670333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance.
    Erden A; Batu ED; Armagan B; Sönmez HE; Sarı A; Demir S; Bilgin E; Fırat E; Kılıc L; Bilginer Y; Karadag O; Kiraz S; Kalyoncu U
    Biomark Med; 2018 Jun; 12(6):565-572. PubMed ID: 29873519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Colchicine for familial Mediterranean fever (periodic peritonitis).
    N Engl J Med; 1974 Apr; 290(17):973. PubMed ID: 4816996
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum concentration and urinary excretion of beta 2-microglobulin and microalbuminuria in familial Mediterranean fever.
    Saatci U; Ozdemir S; Ozen S; Bakkaloglu A
    Arch Dis Child; 1994 Jan; 70(1):27-9. PubMed ID: 8110003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine in familial Mediterranean fever.
    Lancet; 1977 May; 1(8022):1140-1. PubMed ID: 68234
    [No Abstract]   [Full Text] [Related]  

  • 18. Colchicine resistance and low vitamin D in familial Mediterranean fever.
    Anık A; Abacı A; Ünsal E; Makay B
    Ren Fail; 2016; 38(2):340-1. PubMed ID: 26707648
    [No Abstract]   [Full Text] [Related]  

  • 19. Testicular function in patients with familial Mediterranean fever on long-term colchicine treatment.
    Levy M; Yaffe C
    Fertil Steril; 1978 Jun; 29(6):667-8. PubMed ID: 658478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
    J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.